Pancreatic Cancer News & Features

People have more resources than ever when they’re diagnosed with pancreatic cancer, but there’s still a long way to go.

The discovery could help with earlier detection and improve extremely low survival numbers.

If the current trend continues, researchers say pancreatic cancer among women aged 15 to 34 could grow to 400% of that experienced by men of the same ages by 2040.

Trebek was the host of Jeopardy! since its debut in 1984, and he appeared in nearly 8,000 episodes. The show, in which facts are revealed and contestants provide the matching question,  phrased in a specific way, became a cultural touchstone.

The three-time cancer survivor faced her most recent troubles in late 2018, when she had surgery for lung cancer that was discovered after she broke several ribs in a fall in her chambers. In January of 2020, Ginsburg announced that she was cancer free. But in July she said she was undergoing chemotherapy after a lesion was found on her liver.

It's been a tough month, health-wise, for Ginsburg. On July 17 she announced that she underwent chemotherapy to help fight a recurrence of pancreatic cancer, CNN reported.

Civil rights icon and congressman John Lewis, who had been diagnosed with pancreatic cancer last year, died at the age of 80.

In a statement from the Supreme Court, the 87-year-old senior member of the court's four-member liberal wing says she is able to do her job ''full steam."

He also announced he plans to return to the studio to film new episodes of his wildly popular game show in September. The show's filming has been in hiatus during the coronavirus pandemic.

Olaparib is already approved for use in BRCA-mutated ovarian and breast cancers.

The 79-year-old said he was diagnosed during a "routine medical visit and subsequent tests."

Alex Trebek is turning his battle with pancreatic cancer into advocacy, partnering with the World Pancreatic Cancer Coalition to issue a public service announcement (PSA) aimed at heightening awareness of the killer disease.

Colon cancer rates and pancreatic cancer deaths rose by 10% worldwide between 1990 and 2017, according to a new study of global trends in digestive diseases.

The 79-year-old Trebek resumed chemotherapy last month after losing a large amount of weight and having his cancer-related numbers rise sharply, he told ABC's "Good Morning America" on Sept. 17.

The finding could advance the prevention and treatment of pancreatic cancer, which is usually fatal because it's often detected too late.

"Jeopardy!" host Alex Trebek is heading back for another round of chemotherapy after losing a large amount of weight and having his numbers rise sharply, he told ABC's "Good Morning America" on Tuesday.

Long-time "Jeopardy!" host Alex Trebek has finished chemotherapy -- aimed at beating back pancreatic cancer -- and is returning to host the popular game show.

Justice Ruth Bader Ginsburg has just finished treatment for pancreatic cancer, the U.S. Supreme Court announced Friday.

In the clinical trial, 49 patients with locally advanced pancreatic cancer received intensive chemotherapy and radiation therapy, as well as the blood pressure drug losartan.

New chemotherapy regimens have given people with inoperable pancreatic cancer a fighting chance when delivered appropriately in conjunction with radiation therapy and surgery, according to a new study.

One reason pancreatic cancer is so deadly is that it often isn't discovered until it has reached an advanced stage. The disease rarely causes noticeable symptoms, and there are no effective screening tests, according to the cancer society.

The long-time host of the hit game show announced the diagnosis on the show's YouTube page. Trebek vowed to fight the disease.

Experts say the findings represent major progress against a highly lethal disease.

Your odds of getting pancreatic cancer can quadruple if you’re obese as a teen, researchers have found. But it’s still rare, and even with increased odds, the likelihood of getting the disease is small.

A four-drug chemo "cocktail" extended surgical patients' lives by nearly two years over the current standard single-drug chemo regimen for pancreatic cancer, a clinical trial out of France has shown.